76 related articles for article (PubMed ID: 23480806)
1. Gene expression-based diagnostics for molecular cancer classification of difficult to diagnose tumors.
Schnabel CA; Erlander MG
Expert Opin Med Diagn; 2012 Sep; 6(5):407-19. PubMed ID: 23480806
[TBL] [Abstract][Full Text] [Related]
2. Personalized oncology: recent advances and future challenges.
Kalia M
Metabolism; 2013 Jan; 62 Suppl 1():S11-4. PubMed ID: 22999010
[TBL] [Abstract][Full Text] [Related]
3. Multisite validation study to determine performance characteristics of a 92-gene molecular cancer classifier.
Kerr SE; Schnabel CA; Sullivan PS; Zhang Y; Singh V; Carey B; Erlander MG; Highsmith WE; Dry SM; Brachtel EF
Clin Cancer Res; 2012 Jul; 18(14):3952-60. PubMed ID: 22648269
[TBL] [Abstract][Full Text] [Related]
4. Diagnosis of uncertain primary tumors with the Pathwork tissue-of-origin test.
Monzon FA; Dumur CI
Expert Rev Mol Diagn; 2010 Jan; 10(1):17-25. PubMed ID: 20014919
[TBL] [Abstract][Full Text] [Related]
5. Mixture classification model based on clinical markers for breast cancer prognosis.
Zeng T; Liu J
Artif Intell Med; 2010; 48(2-3):129-37. PubMed ID: 20005686
[TBL] [Abstract][Full Text] [Related]
6. The diagnosis of spinal tumors: established and emerging methods.
Ibrahim GM; Hawkins C; Fehlings MG
Expert Opin Med Diagn; 2012 Mar; 6(2):95-108. PubMed ID: 23480653
[TBL] [Abstract][Full Text] [Related]
7. Blinded comparator study of immunohistochemical analysis versus a 92-gene cancer classifier in the diagnosis of the primary site in metastatic tumors.
Weiss LM; Chu P; Schroeder BE; Singh V; Zhang Y; Erlander MG; Schnabel CA
J Mol Diagn; 2013 Mar; 15(2):263-9. PubMed ID: 23287002
[TBL] [Abstract][Full Text] [Related]
8. Molecular classification of unknown primary cancer.
Bender RA; Erlander MG
Semin Oncol; 2009 Feb; 36(1):38-43. PubMed ID: 19179186
[TBL] [Abstract][Full Text] [Related]
9. Accurate classification of non-small cell lung carcinoma using a novel microRNA-based approach.
Bishop JA; Benjamin H; Cholakh H; Chajut A; Clark DP; Westra WH
Clin Cancer Res; 2010 Jan; 16(2):610-9. PubMed ID: 20068099
[TBL] [Abstract][Full Text] [Related]
10. [Traditional and innovative diagnostic tools: when and why they should be applied].
Cancrini G; Iori A
Parassitologia; 2004 Jun; 46(1-2):173-6. PubMed ID: 15305711
[TBL] [Abstract][Full Text] [Related]
11. A refined symptom-based approach to diagnose pulmonary tuberculosis in children.
Marais BJ; Gie RP; Hesseling AC; Schaaf HS; Lombard C; Enarson DA; Beyers N
Pediatrics; 2006 Nov; 118(5):e1350-9. PubMed ID: 17079536
[TBL] [Abstract][Full Text] [Related]
12. Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization Step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone).
Pergolizzi J; Böger RH; Budd K; Dahan A; Erdine S; Hans G; Kress HG; Langford R; Likar R; Raffa RB; Sacerdote P
Pain Pract; 2008; 8(4):287-313. PubMed ID: 18503626
[TBL] [Abstract][Full Text] [Related]
13. MicroRNAs as potential target gene in cancer gene therapy of gastrointestinal tumors.
Tazawa H; Kagawa S; Fujiwara T
Expert Opin Biol Ther; 2011 Feb; 11(2):145-55. PubMed ID: 21219233
[TBL] [Abstract][Full Text] [Related]
14. Cancer Drug Development: New Targets for Cancer Treatment.
Curt GA
Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
[TBL] [Abstract][Full Text] [Related]
15. Role of molecular diagnostics in the management of viral hepatitis B.
Chakravarty R
Expert Opin Med Diagn; 2012 Sep; 6(5):395-406. PubMed ID: 23480805
[TBL] [Abstract][Full Text] [Related]
16. Molecular diagnosis of human cancer type by gene expression profiles and independent component analysis.
Zhang XW; Yap YL; Wei D; Chen F; Danchin A
Eur J Hum Genet; 2005 Dec; 13(12):1303-11. PubMed ID: 16205741
[TBL] [Abstract][Full Text] [Related]
17. Advances in personalized therapy for lung cancer.
Kim ES; Pandya KJ
Expert Opin Med Diagn; 2013 Sep; 7(5):475-85. PubMed ID: 23931094
[TBL] [Abstract][Full Text] [Related]
18. Exploring novel targets of basal-like breast carcinoma by comparative gene profiling and mechanism analysis.
Wu YM; Hu W; Wang Y; Wang N; Gao L; Chen ZZ; Zheng WQ
Breast Cancer Res Treat; 2013 Aug; 141(1):23-32. PubMed ID: 23933801
[TBL] [Abstract][Full Text] [Related]
19. Drug development for cancer chemoprevention: focus on molecular targets.
Johnson KA; Brown PH
Semin Oncol; 2010 Aug; 37(4):345-58. PubMed ID: 20816505
[TBL] [Abstract][Full Text] [Related]
20. The 'Sentinel Node' Concept: More Questions Raised than Answers Provided?
Schlag PM
Oncologist; 1998; 3(5):VI-VII. PubMed ID: 10388128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
